Cyclacel Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
BERENSON RONALD J director, officer: President an..
Common Stock 27,272 $0.92 $25,063
Option
BERENSON RONALD J director, officer: President an..
Employee Stock Option (right to buy) 27,272 $0.92 $25,063
Purchase
ARCH MANAGEMENT PARTNERS II LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH V ENTREPRENEURS FUND LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH VENTURE FUND V LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
DELEAGE JEAN other: Nolonger Director or 10%..
Common Stock 125,000 $8 $1,000,000
Purchase
LAZARUS STEVEN 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH VENTURE FUND II LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH VENTURE PARTNERS LLC 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
CRANDELL KEITH 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
NELSEN ROBERT director, 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH VENTURE FUND III L P 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
BYBEE CLINTON 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
HEALTHCARE FOCUS FUND LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
ARCH VENTURE PARTNERS V LP 10 percent owner
Common Stock 187,500 $8 $1,500,000
Purchase
DELEAGE JEAN other: Nolonger Director or 10%..
Common Stock 125,000 $8 $1,000,000

Showing 200 to 216 of 216 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.